(Total Views: 454)
Posted On: 08/26/2019 11:35:41 AM
Post# of 154119
Re: Coco Beans #6663
Welcome to the board CoCo Beans
“I’d like to see a new CEO brought in who has a proven track record of success in bringing a drug to market. I’m tired of all the pontificating.”
The BLA for combo therapy is scheduled to be submitted at the end of next month and if everything goes accordingly, approval with within 6 months of that submission. Replacing NP at this time would not only be costly (an experienced CEO with a history of bringing a drug to the market will cost much, much more than what NP is paid) but unnecessary as NP has gotten leronlimab this far and has an established relationship with the FDA. IMO, removing NP at this time and starting the process to hire another CEO would further delay leronlimab and is most likely not an option that the BOD would approve.
“I’d like to see a new CEO brought in who has a proven track record of success in bringing a drug to market. I’m tired of all the pontificating.”
The BLA for combo therapy is scheduled to be submitted at the end of next month and if everything goes accordingly, approval with within 6 months of that submission. Replacing NP at this time would not only be costly (an experienced CEO with a history of bringing a drug to the market will cost much, much more than what NP is paid) but unnecessary as NP has gotten leronlimab this far and has an established relationship with the FDA. IMO, removing NP at this time and starting the process to hire another CEO would further delay leronlimab and is most likely not an option that the BOD would approve.
(0)
(0)
